KLTOW — Klotho Neurosciences, Inc
NASDAQ · Healthcare · Biotechnology
Klotho Neurosciences, Inc (KLTOW) is a biotechnology company listed on NASDAQ. It is led by Joseph Sinkule Pharm.D., based in 13576 Walnut Street, Omaha, NE, United States, 68144, with about 3 employees. Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Net income was -$3.6K.
Use this KLTOW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KLTOW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KLTOW SEC filings page. Lician reads the product cache first so this HTML stays unique to Klotho Neurosciences, Inc even when a live quote feed is slow.
About Klotho Neurosciences, Inc
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
KLTOW Key Statistics
EPS
$0.00
Revenue
$0.00
Net Income
-$3.56K
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
3
KLTOW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2021 |
|---|---|
| Revenue | $0.00 |
| Cost of Revenue | $0.00 |
| Gross Profit | $0.00 |
| Operating Income | $0.00 |
| Net Income | -$3.56K |
| EPS (Diluted) | $0.00 |
Total Assets
$0.00
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$181.34K
Operating Cash Flow
$4.95K
Free Cash Flow
$0.00
Klotho Neurosciences, Inc Company Information
- Founder, CEO, Chairman of the Board & Secretary
- Joseph Sinkule Pharm.D.
- Headquarters
- 13576 Walnut Street, Omaha, NE, United States, 68144
- Website
- klothoneuro.com
- Phone
- 833 931 6330
- IPO / Founded
- 2024-09-17
- Sector
- Healthcare
- Industry
- Biotechnology